141 results
6-K
EX-99.5
LMNL
Liminal BioSciences Inc.
10 May 22
Liminal BioSciences Reports First Quarter 2022 Financial Results and Business Highlights
4:55pm
, as at the end of the period covered by the interim filings
A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance … ; and
B.designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
40FR12B
EX-99.9
LMNL
Liminal BioSciences Inc.
12 Nov 19
Initial registration of securities (Canada)
6:11am
of the period covered by the interim filings
designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance … , or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
40FR12B
EX-99.3
LMNL
Liminal BioSciences Inc.
12 Nov 19
Initial registration of securities (Canada)
6:11am
it to be designed under our supervision, to provide reasonable assurance that
material information relating to the issuer is made known to us by others … reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
6-K
EX-99.5
LMNL
Liminal BioSciences Inc.
16 Nov 21
Liminal BioSciences Reports Third Quarter 2021 Financial Results
12:00am
of the period covered by the interim filings
designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
material … , or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
6-K
EX-99.4
LMNL
Liminal BioSciences Inc.
17 May 21
Liminal BioSciences Reports First Quarter 2021 Financial Results
5:11pm
by the interim filings
designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
material information relating … it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
40FR12B
EX-99.2
6ko5r8pfg1zh9s87p
12 Nov 19
Initial registration of securities (Canada)
6:11am
40FR12B
EX-99.13
zswn2w4jmpy4 3cp
12 Nov 19
Initial registration of securities (Canada)
6:11am
6-K
EX-99.4
f1561tinj0e
16 Aug 21
Liminal BioSciences Reports Second Quarter 2021 Financial Results
5:08pm
6-K
EX-99.4
ulplo 2cui
16 Nov 21
Liminal BioSciences Reports Third Quarter 2021 Financial Results
12:00am
6-K
EX-99.5
kc0hq8es5zqg
10 Aug 20
Liminal Biosciences Reports Financial Results for Q2-2020
5:11pm
40FR12B
EX-99.7
iev62qzsqqlrkkocp
12 Nov 19
Initial registration of securities (Canada)
6:11am
40FR12B
EX-99.129
7o6jzd
12 Nov 19
Initial registration of securities (Canada)
6:11am
6-K
EX-99.5
9m8zp19k7z3k9 sz7
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
6-K
EX-99.4
8c6yo5eswje mx
10 Aug 20
Liminal Biosciences Reports Financial Results for Q2-2020
5:11pm
6-K
EX-99.4
9ux3 picbzftz7
12 Nov 20
Liminal BioSciences Reports Third Quarter Financial Results
5:07pm
6-K
EX-99.5
c5zu2b
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
6-K
EX-99.4
jomh0rctia4tq4
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
40FR12B
EX-99.5
cawb1izroca
12 Nov 19
Initial registration of securities (Canada)
6:11am
40FR12B
EX-99.10
8kpi5ut
12 Nov 19
Initial registration of securities (Canada)
6:11am
40FR12B
EX-99.130
7wkdsujp3tyfvgb f9eb
12 Nov 19
Initial registration of securities (Canada)
6:11am